Barinthus Biotherapeutics plc
BRNS
$0.74
-$0.02-2.49%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -31.26% | -33.56% | -36.33% | -30.00% | -26.76% |
| Total Receivables | -67.58% | -63.75% | -81.72% | -76.72% | -11.52% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -70.60% | -22.51% | -22.89% | -23.39% | -18.73% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -82.59% | -19.57% | -27.43% | 374.78% | 346.01% |
| Total Current Assets | -36.99% | -33.87% | -38.14% | -35.55% | -23.86% |
|
|
|||||
| Total Current Assets | -36.99% | -33.87% | -38.14% | -35.55% | -23.86% |
| Net Property, Plant & Equipment | -40.59% | -51.28% | -56.10% | -63.76% | -57.05% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -35.95% | -35.40% | -34.90% | -34.43% | -13.44% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.65% | 1.33% | 5.56% | 0.32% | 6.55% |
| Total Assets | -36.79% | -35.11% | -38.77% | -42.13% | -30.62% |
|
|
|||||
| Total Accounts Payable | -70.28% | -26.82% | -85.85% | -77.31% | -29.58% |
| Total Accrued Expenses | 19.89% | 6.59% | -34.39% | -16.13% | -28.35% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -15.32% | 2.30% | 5.36% | 1.56% | 6.26% |
| Total Finance Division Other Current Liabilities | -78.03% | -8.90% | -19.68% | -31.41% | 81.76% |
| Total Other Current Liabilities | -78.03% | -8.90% | -19.68% | -31.41% | 81.76% |
| Total Current Liabilities | -10.23% | 0.21% | -36.02% | -28.36% | -18.37% |
|
|
|||||
| Total Current Liabilities | -10.23% | 0.21% | -36.02% | -28.36% | -18.37% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -13.88% | -9.60% | -8.22% | -10.58% | -6.59% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.22% | 4.32% | 3.44% | 23.50% | 18.49% |
| Total Liabilities | -8.57% | -2.80% | -20.92% | -15.70% | -9.61% |
|
|
|||||
| Common Stock & APIC | 0.32% | 0.14% | 0.12% | 0.35% | 0.87% |
| Retained Earnings | -15.00% | -20.33% | -27.95% | -34.95% | -33.22% |
| Treasury Stock & Other | -37.36% | 12.61% | 39.32% | -2.05% | 47.86% |
| Total Common Equity | -44.25% | -42.51% | -42.93% | -46.98% | -34.63% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -44.25% | -42.51% | -42.93% | -46.98% | -34.63% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -41.35% | -20.20% | -20.75% | -42.51% | -39.53% |
| Total Equity | -44.25% | -42.49% | -42.91% | -46.97% | -34.64% |
|
|
|||||